YOLFTbeta
Real Heart

Real Heart

HEART · ST · Healthcare / Medical Devices

15.80SEK+0.40 (+2.60%)

Price History

Full chart

Market Stats

Previous Close15.40
Open15.85
Day Range14.05 – 15.85
52-Week Range12.89 – 30.00
Volume2.12K
Market Cap154.66M
P/E (TTM)0.00
Forward P/E0.00
EPS-5.67
Dividend Yield0.00%
Beta1.18
50-Day Avg18.62
200-Day Avg17.04

About

Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart. The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis for fixing the sternum after open-chest surgery. The company was founded in 1999 and is based in Västerås, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Ina Laura Perkins
  • Employees18
  • HeadquartersKopparbergsvAegen 6, Västerås, Sweden, 722 13, Sweden
  • Websitehttps://realheart.se

Leadership

  • Dr. Azad NajarFounder, Chief Innovation Officer, Head of Product Development & Innovation and Director · b. 1968
  • Dr. Ina Laura PerkinsMD & CEO
  • Mr. Jimmy NybomChief Financial Officer · b. 1978
  • Mr. Thomas FinocchiaroChief Technology Officer · b. 1976
  • Dr. Ulf KjellmanChief Medical Officer & Member of Medical Advisory Board

Financials

Income Statement

Currency: SEK2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue121-443226.26K148.05K132.67K774.97K111.35K00010.00K000
Growth (%)--91.67%--+50973.81%-34.56%-10.39%+484.11%-85.63%-100.00%----100.00%--
Cost of Revenue-----1.66M3.94M2.20M2.04M-3.96M-333.00K233.69K-12.28M50.22M164.70K245.60K
Gross Profit121-443226.26K-1.51M-3.80M-1.43M-1.93M3.96M332.76K7.20M12.29M-50.22M-164.70K-245.60K
Gross Margin100.00%100.00%-100.00%100.00%-1021.25%-2867.18%-184.14%-1735.12%---122870.00%---
Operating Expense116.59K86.45K-236.44K1.89M008.54M6.59M11.05M8.97M17.53M26.14M-32.70M14.97M15.09M
Operating Income-116.58K-86.45K-10.91K-236.00K-1.66M-1.51M-3.80M-9.97M-8.52M-7.09M-8.64M-10.33M-13.85M-17.52M-15.13M-15.34M
Operating Margin-971458.33%-8645400.00%--53273.14%-734.56%-1021.25%-2867.18%-1286.51%-7650.86%----138510.00%---
EBITDA-75.09K-40.43K22.59K-213.00K-1.63M-1.47M-3.71M-13.46M-8.53M-6.83M-8.37M-10.09M-13.73M-67.25M-33.54M-15.09M
EBITDA Margin-625716.67%-4043000.00%--48081.26%-722.19%-992.21%-2800.10%-1736.98%-7664.33%----137350.00%---
Net Income-116.79K-86.59K-13.47K-258.00K-1.69M-1.53M-3.88M-13.74M-8.86M-7.29M-8.82M-10.48M-13.99M-67.98M-34.35M-35.50M
Net Income Margin-973258.33%-8659500.00%--58239.28%-746.94%-1034.08%-2927.48%-1773.49%-7955.31%----139880.00%---
Interest Expense216141-21.29K27.98K18.93K79.72K145.56K188.72K198.85K180.95K156.53K137.70K572.03K641.47K372.79K
Interest Expense % of Total Revenue1800.00%14100.00%-4805.42%12.37%12.78%60.09%18.78%169.49%---1377.01%---

Balance Sheet

Currency: SEK2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets971.28K873.53K1.24M1.38M8.35M6.60M20.21M33.96M27.42M66.61M78.04M117.82M119.82M102.64M83.28M72.69M
Total Liabilities72.65K61.49K438.75K842.11K857.12K631.85K4.01M6.44M8.12M7.61M6.35M6.53M22.17M20.60M15.94M10.20M
Total Equity898.64K812.04K798.57K541.04K7.50M5.97M16.20M27.52M19.30M59.00M71.69M111.29M97.65M82.04M67.34M62.49M
Cash395.08K242.77K36.74K88.03K5.60M1.90M8.77M17.36M3.68M25.42M22.45M42.67M11.26M43.30M23.72M16.57M
Total Debt----75.00K218.75K2.57M4.00M4.00M3.71M3.42M2.80M2.17M8.25M6.35M4.46M
Net Debt-395.08K-242.77K-36.74K-88.03K-5.52M-1.69M-6.21M-13.36M315.06K-21.70M-19.04M-39.88M-9.09M-35.05M-17.36M-12.11M

Cash Flow

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.77M-1.40M-3.49M-9.86M-6.45M-7.32M-9.41M-9.65M-7.38M-25.05M-12.99M-15.66M
Investing Cash Flow-838.06K-2.22M-6.18M-8.05M-7.87M-17.65M-14.76M-19.59M-23.76M-1.77M-24.28M-26.11M
Financing Cash Flow8.11M-75.00K16.54M26.49M638.90K46.71M21.21M49.46M-276.28K58.87M17.69M34.62M
Capital Expenditure846.44K2.22M6.18M8.05M7.87M17.65M14.76M19.59M23.76M1.77M25.26M865.13K
Free Cash Flow-2.61M-3.62M-9.67M-17.91M-14.32M-24.98M-24.18M-29.24M-31.14M-26.82M-38.25M-16.53M
FCF to OCF147.92%258.57%277.20%181.63%222.03%341.09%256.88%302.92%421.91%107.08%294.43%105.52%

Earnings

Report DateDec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Dec 31, 2023Dec 31, 2024Mar 31, 2025Jun 30, 2025
EPS Estimate---------------------------------
EPS Actual-0.05-0.07-0.12-0.06-0.07-0.04-0.08-0.12-0.76-0.07-0.09-0.12-0.28-0.57-0.12-0.070.38-0.12-0.10-0.11-0.09-0.08-0.10-0.06-6.80-3.63-4.31-5.68-4.03-36.41-4.98-4.58-1.98
Surprise---------------------------------
Timing---------------------------------

Key Statistics & Ratios

Market Cap154.66M
Enterprise Value123.26M
Trailing P/E0.00
Forward P/E0.00
Price / Sales8295.87
Price / Book1.80
EPS-5.67
Book Value10.44
Revenue (TTM)153.10K
Gross Profit (TTM)29.84M
EBITDA-34.63M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-50.08%
Return on Assets-27.51%
Shares Outstanding8.50M
Shares Float5.54M
Beta1.18
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Nov 21, 20241:100